Isabelle Racamier
Vorstandsvorsitzender bei Esocap AG
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jacques Gonella | M | 82 |
Esocap AG
 Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
| Werner Tschollar | M | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
| Christoph Sven Hoffmann | M | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
| Urs Breitenstein | M | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
| Patrick Susse | M | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
| Werner Weitschies | M | - |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Frédéric Tarbouriech | M | - | - | |
| Jean-Yves Nothias | M | 62 | 4 Jahre | |
| Neil Butler | M | - | 4 Jahre | |
| Bruno Chalom Sayada | M | - | 10 Jahre | |
| Bernard Malfroy-Camine | M | 71 | 11 Jahre | |
| Tamar Saraga | F | - | - | |
| Beth Jacobs | F | - | 4 Jahre | |
| Stéphane Altaba | M | - | - | |
| Thomas Rühle | M | 63 |
MSD Vaccines GmbH
 MSD Vaccines GmbH Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD GmbH is an Austrian company that manufactures and distributes vaccines. The joint venture company is based in Brunn am Gebirge, Austria. The company was founded in 1994. The CEO is Oliver Sadlek. | 6 Jahre |
| Dominique Remy-Renou | F | - | 2 Jahre | |
| Yamina Ghomchi | M | - | 11 Jahre | |
| Barradeau S. | M | - | 3 Jahre | |
| Caulliez C. | M | - | 2 Jahre | |
| Peter Coudenys | M | - | 3 Jahre | |
| Florian Schödel | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 14 | 66,67% |
| Schweiz | 6 | 28,57% |
| Österreich | 1 | 4,76% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Isabelle Racamier
- Persönliches Netzwerk